Market Factors - Growth, Barriers, and Opportunity Analysis Clinical Reclassification of Obesity as a Chronic Metabolic Disease Global healthcare systems are increasingly recognizing obesity as a chronic metabolic condition requiring pharmacological intervention
The application of NICE guidelines outside of England varies: Scotland, Wales, and Northern Ireland: These parts of the UK have their own guideline development bodies (SIGN, TGCS, and BSG, respectively)
Common side effects include mild injection site reactions, headaches, dizziness, nausea, and, in rare cases, allergic reactions
Nuts and seeds : Walnuts, almonds, and sunflower seeds provide essential nutrients for glutathione production
It is important to distinguish between a direct pharmacologic effect of the medication and indirect consequences of the physiologic changes these drugs produce
Our team evaluates these differences to help patients select the medication that best aligns with their goals